Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Fibrocell Finds New Life In
Exhibit 1 Top Alliances In May 2015 Potential Deal Value* *Potential deal value is the sum of up-front fees plus pre-commercialization money. Strategic Transactions Exhibit 2 Top Mergers & Acquisition
IN VITRO DIAGNOSTICS Alliances Biohit Oyj Mekalasi Oy Mekalasi Oy agreed to distribute four of Biohit Oyj ’s Quick Tests in Finland. (May) Included in the deal are the Heliobacter Pylori UFT300